Furthermore, reduced tumor growth and decrease in HER2 and Ki67 immunostaining were detected in SKOV3.ip xenografts upon in vivo treatment with D609, pointing to the interest of further evaluating the potential role of PC-PLC as a therapy target in preclinical HER2-overexpressing EOC models. The gene discussed is ERBB2; the disease is neoplasm.